Ketamine and Kidney Injury in Cardiac Surgery

StatusActive, Not Recruiting
PhasePhase 4
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 20, 2026
    • Primary endpoint(s) modified
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoint revised
  2. Study completion date: Jun 2026 to Jun 1, 2027v7
  3. Primary completion date changed from estimate of Aug 2025 to Sep 5, 2025v6
  4. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jun 2025 to Aug 2025
    • Study completion date: Jun 2025 to Jun 2026
    • Site details revised
    v5
  5. Primary and study completion dates: Dec 2024 to Jun 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary and study completion dates: Dec 2023 to Dec 2024v3
  2. Primary and study completion dates pushed to Dec 2023v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,027 trials monitored
See 130 trials at risk
The purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.
Trial Details
NCT Number NCT05268562
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Cardiac Surgery
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov